Oviya MedSafe MD & CEO Dr J Vijay Venkatraman to Chair the...

Oviya MedSafe MD & CEO Dr J Vijay Venkatraman to Chair the 2 nd Indian Pharmacovigilance Day Conference at Hyderabad

The conference will be held at Hotel Lemon Tree Premier, Hitec City on Friday 28-July-2017

Dr J Vijay Venkatraman, Managing Director & Chief Executive Officer of Oviya MedSafe, a global Pharmacovigilance consulting and Drug Safety services-providing organization based at Coimbatore, India and London, UK has been invited to Chair the ‘Indian Pharmacovigilance Day 2017’ conference, which is to be held on Friday 28 th July 2017 at Hotel Lemon Tree Premier, Hitec City, Hyderabad. It may be relevant to recall that Dr Vijay has been the Chair of all the three annual editions of the UK Pharmacovigilance Day conference since its launch in 2015 & the 1st Indian Pharmacovigilance Day conference in 2016, which were successfully organized at London and in Mumbai respectively.

The ‘Pharmacovigilance Day‘ series of conferences has been organized in different parts of the world by EasyB srl, an Italian company that specializes in producing conferences and seminars dedicated to the pharmaceutical sector such as clinical research, pharmacovigilance, statistics and epidemiology, since 2008. The ‘Pharmacovigilance Day’ series of events aspire to bring together Drug Safety experts from the pharmaceutical and healthcare industry: pharma & medical devices companies, biotechnology firms, government agencies, academic research and so on, from a specific country or region with the aim of providing a platform for discussing pharmacovigilance issues that are unique to the concerned country/region.

While speaking to the media, Dr J Vijay Venkatraman said, “India is globally recognized as a hub for generic drug manufacturing and the Indian pharmaceutical industry has carved a niche for itself in exporting its products to many developed as well as emerging countries. Of late, India is also being seen as a target destination for procurement of support services required for the global pharmaceutical industry, especially in pharmacovigilance. Simultaneously, we have seen changes for the better in Indian Pharmacovigilance such as XML-E2B format reporting of ICSRs to the Pharmacovigilance Programme of India (PvPI) and the March 8th 2016 dated gazette notification legally mandating pharmacovigilance for all pharmaceutical companies. With news of the revised draft of the ‘Pharmacovigilance Guidelines for Marketing Authorization Holders of Pharmaceutical Products in India’ being close to finalization by the Indian regulatory authorities, understanding pharmacovigilance is now a compelling need for all the stakeholders in India.

At this ripe moment, the task of integrating and streamlining the opinions and expectations of all stakeholders of Indian pharmacovigilance assumes significant relevance. The Indian Pharmacovigilance Day 2017 conference is all set to achieve this formidable goal with immense focus and dedication. During the conference, expert speakers from the industry, health authorities, research bodies, academia and healthcare delivery centres will share their perspectives on the multifaceted outlook of the discipline of pharmacovigilance in India and deliberate on the challenges they expect to face in 2017, covering several aspects of pharmacovigilance that India is involved in.”

Mr. Enrico Pedroni, Managing Director of EasyB srl based in Bergamo, Italy expressed his happiness in organizing their second event in India. “It was a pleasant experience for us to work with Dr J Vijay Venkatraman when he was the Chair of our UK and Indian Pharmacovigilance Day conferences so far. His passion for pharmacovigilance, his extensive network of pharmacovigilance stakeholders and his willingness to go the extra mile to personally interact with all potential speakers were great contributors for the success of the 1st Indian Pharmacovigilance Day which was held at Mumbai last year. We further came to understand that Hyderabad is an international pharmaceutical hub which has not seen any pharmacovigilance conference in the recent years. Hence, we felt we should organize the 2 nd Indian Pharmacovigilance Day at Hyderabad on 28-July-2017, again with Dr Vijay at the helm of affairs, in order to re-write our success story in Hyderabad too”, he said. He added that the one-day conference has been designed to benefit functional / technical professionals working in the pharmacovigilance / regulatory / medical affairs / marketing domains in organizations involved in pharmaceutical manufacturing / drug marketing / contract research, healthcare professionals in patient care, clinical investigators & research staff, academia and government health agencies, among others, Mr Pedroni remarked.

For more information on the conference and the modus operandi of registration, please visit the website www.pharmacovigilanceday.com.

 

 

NO COMMENTS

Leave a Reply


*